PRRT2 and atherosclerosis: The protein kinase C (PKC) and extracellular signal-regulated kinase 1/2 (ERK1/2) pathways are also activated, further promoting fibroblast proliferation and migration, which drive adventitial inflammation and atherosclerosis.